- $331.56m
- $261.42m
- $11.28m
- 43
- 18
- 47
- 28
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.75 | ||
| Price to Tang. Book | 2.78 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 29.39 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.95% | ||
| Return on Equity | -27.83% | ||
| Operating Margin | -502.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 1.3 | 8.58 | 9.9 | 11.28 | 22.75 | 63.24 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
Directors
- Ran Poliakine CHM
- Itzhak Maayan CFO (55)
- James Dara COO (51)
- Ofir Koren CTO (51)
- Tamar Cohen CMO (49)
- Anat Kaphan VPR (51)
- Shirly Kirshenbaum VPR (46)
- Tal Shank VPR (43)
- Onn Fenig DRC (46)
- Floyd Katske DRC (69)
- Jung Ho Park DRC (57)
- Richard Stone DRC (78)
- Noga Kainan IND (67)
- Erez Meltzer IND (64)
- Dan Suesskind IND (77)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 20th, 2018
- Public Since
- August 21st, 2020
- No. of Employees
- 165
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 63,762,001
- Address
- Ofer Tech Park, 94 Shlomo Shmeltzer Road, PETAH TIKVA, 4970602
- Web
- https://www.nanox.vision/
- Phone
- +972 37359202
- Contact
- Mike Cavanaugh
- Auditors
- Kesselman & Kesselman
Upcoming Events for NNOX
Q2 2025 Nano-X Imaging Ltd Earnings Release
Similar to NNOX
908 Devices
NASDAQ Global Market
Alpha Teknova
NASDAQ Global Market
Anteris Technologies Global
NASDAQ Global Market
AtriCure
NASDAQ Global Market
Beta Bionics
NASDAQ Global Market
FAQ
What is the Nano-X Imaging share price?
As of Today at 22:11 UTC, shares in Nano-X Imaging are trading at $5.20. This share price information is delayed by 15 minutes.
How has the Nano-X Imaging share price performed this year?
Shares in Nano-X Imaging last closed at $5.20 and the price had moved by -44.39% over the past 365 days. In terms of relative price strength the Nano-X Imaging share price has underperformed the S&P500 Index by -47.71% over the past year.
What are the analyst and broker recommendations for Nano-X Imaging?
The overall consensus recommendation for Nano-X Imaging is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Nano-X Imaging dividend yield?
Nano-X Imaging does not currently pay a dividend.
Does Nano-X Imaging pay a dividend?
Nano-X Imaging does not currently pay a dividend.
When does Nano-X Imaging next pay dividends?
Nano-X Imaging does not currently pay a dividend.
How do I buy Nano-X Imaging shares?
To buy shares in Nano-X Imaging you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nano-X Imaging?
As of the previous close price of $5.20, shares in Nano-X Imaging had a market capitalisation of $331.56m.
Where are Nano-X Imaging shares listed?
Here are the trading details for Nano-X Imaging:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: NNOX
What kind of share is Nano-X Imaging?
Based on an overall assessment of its quality, value and momentum Nano-X Imaging is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nano-X Imaging share price forecast for 2025?
The analyst consensus target price for shares in Nano-X Imaging is $11.00. That is 111.54% above the last closing price of $5.20.
Analysts covering Nano-X Imaging currently have a consensus Earnings Per Share (EPS) forecast of -$0.74 for the next financial year.
Find out moreWhat is the trend in the Nano-X Imaging share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nano-X Imaging. Over the past six months, its share price has underperformed the S&P500 Index by -5.84%.
As of the last closing price of $5.20, shares in Nano-X Imaging were trading -21.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nano-X Imaging PE Ratio?
The Nano-X Imaging PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nano-X Imaging?
Nano-X Imaging's management team is headed by:
- Ran Poliakine - CHM
- Itzhak Maayan - CFO
- James Dara - COO
- Ofir Koren - CTO
- Tamar Cohen - CMO
- Anat Kaphan - VPR
- Shirly Kirshenbaum - VPR
- Tal Shank - VPR
- Onn Fenig - DRC
- Floyd Katske - DRC
- Jung Ho Park - DRC
- Richard Stone - DRC
- Noga Kainan - IND
- Erez Meltzer - IND
- Dan Suesskind - IND